APOE and atherosclerosis: Moreover, ApoE−/− mice with a heterozygous deletion of the IR and its downstream target, IR substrate 1 (IRS1), also develop accelerated atherosclerosis [6], as well as the mice lacking IR substrate 2 (IRS2−/−) [7].